This article is more than 5 years old. Information may no longer be current.
Top five articles from Heart in Diabetes
The Heart in Diabetes Clinical Education Conference met July 13-15 in Philadelphia. Endocrine Today was there to cover breaking news and new research in endocrinology.
Below are the five most read articles from the meeting posted on Healio.com/Endocrinology:
Most adults with diabetes, CVD do not meet secondary prevention targets
Less than one-third of adults with diabetes and cardiovascular disease achieve goals for secondary prevention, including smoking cessation, use of prophylactic medications, and blood pressure and lipid control.
Cardiologists should consider prescribing GLP1 agents for CVD prevention in type 2 diabetes
Although endocrinologists may routinely prescribe the newer classes of diabetes drugs approved for cardiovascular risk reduction, cardiologists and primary care providers should also consider using these agents for patients with type 2 diabetes and heart disease.
Consumer technology poised to improve diabetes, CVD management
Wearable technologies may soon play a larger role in prevention and management of diabetes and heart disease.
Newer diabetes agents show promise for renal disease
Large cardiovascular outcome trials for antidiabetes agents in two drug classes have yielded potentially promising data with respect to their secondary renal outcomes, offering new options for patients with diabetic kidney disease.
Lifestyle changes necessary for mitigating cardiometabolic risk
Lifestyle modifications, such as adherence to a healthy diet, smoking cessation and adequate exercise, are a must to help reduce cardiometabolic disease risk.
See more coverage from the meeting.